1. Academic Validation
  2. Juglanin suppresses oscillatory shear stress-induced endothelial dysfunction: An implication in atherosclerosis

Juglanin suppresses oscillatory shear stress-induced endothelial dysfunction: An implication in atherosclerosis

  • Int Immunopharmacol. 2020 Dec;89(Pt B):107048. doi: 10.1016/j.intimp.2020.107048.
Jian Zhao 1 Xiaoqiang Quan 1 Zhouliang Xie 1 Leilei Zhang 1 Zhiwei Ding 1
Affiliations

Affiliation

  • 1 Department of Cardiovascular Surgery, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Henan, China.
Abstract

Introduction: Atherosclerosis is characterized by endothelial cell dysfunction followed by lesion formation, arterial stenosis, potentially arterial occlusion, and severe outcomes. Novel treatments to slow or prevent the progression of the disease are of considerable clinical value. In the present study, we investigated the potential anti-atherosclerotic effects of the natural product juglanin in oscillatory shear stress (OSS) exposed endothelial cells.

Methods: Human aortic endothelial cells (HAECs) were exposed to OSS generated by a micro fluidal Teflon cone at 1 Hz frequency cycles (±5 dyn/cm2) in the presence or absence of 2.5 and 5 μM juglanin for 24 h. The expression levels of inflammatory factors and vascular adhesion molecules were evaluated using qRT-PCR, Western Blot, and ELISA. DHE assay was used to detect the production of ROS. The monocytic THP-1 cells were labeled with calcein-AM and incubated with HAECs for adhesion assay.

Results: Juglanin reduces OSS-induced oxidative stress by reducing the production of ROS through downregulation of NOX-2 and rescuing OSS-induced reduced expression of eNOS. Juglanin also inhibits the inflammatory response by suppressing OSS-induced expressions of IL-1β, MCP-1, and HMGB1. Using THP-1 monocytes, we show that juglanin reduces the attachment of monocytes to endothelial cells by inhibiting the expression of VCAM-1 and E-Selectin. Moreover, Juglanin rescues OSS-reduced expression of atheroprotective transcriptional factor KLF2.

Conclusions: Our findings indicate that juglanin protects against various atheroprone OSS-induced endothelial dysfunction. Juglanin has potential implication as a candidate for vascular intervention of atherosclerosis.

Keywords

Cardiovascular disease; Inflammation; Juglanin; KLF2; Oscillatory shear stress (OSS).

Figures
Products